Literature DB >> 2928989

Prognostic value of bronchoalveolar lavage in sarcoidosis: the critical influence of disease presentation.

K Ward1, C O'Connor, C Odlum, M X Fitzgerald.   

Abstract

There has been considerable disagreement about the prognostic value of bronchoalveolar lavage lymphocyte measurements in patients with sarcoidosis. This study looks at the influence of the type of disease presentation and the time since onset of symptoms on lavage fluid lymphocyte profiles in 99 patients studied at the time of their initial diagnosis. Patients who had an acute inflammatory onset of disease with erythema nodosum (n = 32) or acute uveitis (n = 17) almost invariably had high T lymphocyte helper:suppressor (TH:TS) ratios (mean 10.1, 95% confidence interval 7.7-12.5) and had a higher proportion of T lymphocytes in cells obtained at lavage (40%, 35-46%) than patients with a pulmonary presentation (n = 38) (TH:TS 2.9, 0.2-5.7; T lymphocytes 21%, 15-27%) or those studied after resolution of erythema nodosum (n = 12). The patients with recent erythema nodosum had the highest TH:TS ratios of any group (10.4, 8.1-12.7). Thus lavage T lymphocyte percentage and TH:TS are highest in patients with sarcoidosis studied soon after an acute onset with an inflammatory condition such as erythema nodosum or uveitis. Patients with an acute onset of sarcoidosis have a better prognosis than those with a more insidious presentation. The major influence of type of disease presentation and, in the case of patients with erythema nodosum, of time since onset of symptoms may in part explain why different centres have reported such diverse results regarding the value of bronchoalveolar lavage in predicting outcome in sarcoidosis. Studies where the case mix of patients includes a high proportion of patients with acute onset will not find a high TH:TS ratio or increased numbers or proportions of lavage lymphocytes to be indicators of a poor prognosis.

Entities:  

Mesh:

Year:  1989        PMID: 2928989      PMCID: PMC461656          DOI: 10.1136/thx.44.1.6

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  13 in total

1.  Corticosteroid treatment in pulmonary sarcoidosis: do serial lavage lymphocyte counts, serum angiotensin converting enzyme measurements, and gallium-67 scans help management?

Authors:  M Turner-Warwick; W McAllister; R Lawrence; A Britten; P L Haslam
Journal:  Thorax       Date:  1986-12       Impact factor: 9.139

2.  Predictive value of bronchoalveolar T cell subsets for the course of pulmonary sarcoidosis.

Authors:  U Costabel; K J Bross; J Guzman; A Nilles; K H Rühle; H Matthys
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

Review 3.  Alveolitis: the key to the interstitial lung disorders.

Authors:  B A Keogh; R G Crystal
Journal:  Thorax       Date:  1982-01       Impact factor: 9.139

4.  Bronchoalveolar lavage for the preparation of free lung cells: technique and complications.

Authors:  P Cole; C Turton; H Lanyon; J Collins
Journal:  Br J Dis Chest       Date:  1980-07

5.  Antigen-specific identification and cloning of hybridomas with a fluorescence-activated cell sorter.

Authors:  D R Parks; V M Bryan; V T Oi; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

6.  Sarcoidosis: clinical features and management.

Authors:  L E Siltzbach
Journal:  Med Clin North Am       Date:  1967-03       Impact factor: 5.456

7.  The alveolitis of pulmonary sarcoidosis. Evaluation of natural history and alveolitis-dependent changes in lung function.

Authors:  B A Keogh; G W Hunninghake; B R Line; R G Crystal
Journal:  Am Rev Respir Dis       Date:  1983-08

8.  Pulmonary sarcoidosis: alterations in bronchoalveolar lymphocytes and T cell subsets.

Authors:  A P Greening; P Nunn; N Dobson; M Rudolf; A D Rees
Journal:  Thorax       Date:  1985-04       Impact factor: 9.139

9.  Thymus-dependent membrane antigens in man: inhibition of cell-mediated lympholysis by monoclonal antibodies to TH2 antigen.

Authors:  R L Evans; D W Wall; C D Platsoucas; F P Siegal; S M Fikrig; C M Testa; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

10.  Assessment of interlobar variation of bronchoalveolar lavage cellular differentials in interstitial lung diseases.

Authors:  J G Garcia; R G Wolven; P L Garcia; B A Keogh
Journal:  Am Rev Respir Dis       Date:  1986-03
View more
  15 in total

1.  Intracellular cytokine repertoire in different T cell subsets from patients with sarcoidosis.

Authors:  M Möllers; S P Aries; D Drömann; B Mascher; J Braun; K Dalhoff
Journal:  Thorax       Date:  2001-06       Impact factor: 9.139

2.  Th1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ T cells.

Authors:  A Prasse; C G Georges; H Biller; H Hamm; H Matthys; W Luttmann; J C Virchow
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

Review 3.  Future directions for bronchoalveolar lavage.

Authors:  S I Rennard
Journal:  Lung       Date:  1990       Impact factor: 2.584

4.  (18)F-FDG PET patterns and BAL cell profiles in pulmonary sarcoidosis.

Authors:  Ruth G Keijsers; Jan C Grutters; Heleen van Velzen-Blad; Jules M van den Bosch; Wim J Oyen; Fred J Verzijlbergen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-02-16       Impact factor: 9.236

Review 5.  Interstitial lung disease: progress and problems.

Authors:  S J Bourke
Journal:  Postgrad Med J       Date:  2006-08       Impact factor: 2.401

6.  Bronchoalveolar lavage cell counts as a predictor of short term outcome in pulmonary sarcoidosis.

Authors:  N M Foley; A P Coral; K Tung; B N Hudspith; D G James; N M Johnson
Journal:  Thorax       Date:  1989-09       Impact factor: 9.139

7.  Pulmonary sarcoidosis with a diffuse ground glass pattern on the chest radiograph.

Authors:  A Tazi; T Desfemmes-Baleyte; P Soler; D Valeyre; A J Hance; J P Battesti
Journal:  Thorax       Date:  1994-08       Impact factor: 9.139

Review 8.  Clinical and immunologic components of sarcoidosis.

Authors:  Andrea T Borchers; Calvin So; Stanley M Naguwa; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2003-12       Impact factor: 8.667

9.  Spontaneous interleukin 2 release of bronchoalveolar lavage cells in sarcoidosis is a codeterminator of prognosis.

Authors:  J Müller-Quernheim; S Pfeifer; K Kienast; G Zissel
Journal:  Lung       Date:  1996       Impact factor: 2.584

10.  BAL fluid cells in newly diagnosed pulmonary sarcoidosis with different clinical activity.

Authors:  Edvardas Danila; Laimute Jurgauskiene; Jolita Norkuniene; Radvile Malickaite
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.